UPM Pharmaceuticals appoints Chris Curtin as Chief Operating Officer

UPM Pharmaceuticals, a Contract Development and Manufacturing Organization (CDMO) focused on solid oral and semi-solid dosage forms, has appointed Chris Curtin as Chief Operating Officer. Mr. Curtin was promoted from his previous role as Executive Vice President of Quality Operations. Mr. Curtin will lead the organization responsible for Research & Development, Manufacturing, Quality Assurance, Inventory Management, Quality Control and Analytical Services.

Continue reading

Contractors Take on the Challenge of Complex Molecules

Originally published on 9/01/2018 at Drug Development & Delivery

Continue reading

UPM Pharmaceuticals Successfully Serializes Its First Pharmaceutical Product

UPM Pharmaceuticals successfully serialized their first product in May of this year. UPM anticipates having all of their clients' products serialized by November 2017. In accordance with the Drug Supply Chain Security Act which had mandated that pharmaceutical manufacturers serialize all pharmaceutical products starting in November 2017, UPM is excited to be ahead of schedule. All products will be serialized by the FDA’s extended deadline of November 2018, if not before.

Continue reading

UPM Pharmaceuticals on the Road to BIO: Anticipating What’s Around the Bend

Originally published on 6/21/2017 at Pharma's Almanac

Continue reading

Moving Quality to the Forefront Brings Measureable Results

Read our latest article, as published in the Q2 2017 edition of Pharma's Almanac. 

Continue reading

Meeting Customer Needs

Interview originally published on 20/04/2017 at Pharma's Almanac

Continue reading

Expanding Capabilities

Interview originally published on 06/04/2017 at Pharma's Almanac

Continue reading

Experience and Expertise Facilitate Controlled Substance Manufacturing

Read our latest article, as published in the Q1 2017 edition of Pharma's Almanac. 

Continue reading

Designing Effective Drug Formulations: Keys to Successful Proof of Concept Services

Read our latest article, as published in the Q4 2016 edition of Pharma's Almanac. 

Continue reading

UPM Opens Solids Formulation R&D Facility

UPM is excited to announce the opening of its newly designed and qualified Solids Formulation R&D Facility.

Continue reading